Immunogenicity of recombinant Helicobacter pylori urease B administered by various routes and with different adjuvants

Open Vaccine Journal

Volumn 2, Issue , 2009, Pages 28-32

  Bégué, Rodolfo E ^a,b,c   Moll, Alyson ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Research Institute for Children at Children's Hospital New Orleans   (United States)

^c CHILDREN S HOSPITAL   (United States)

Author keywords

Alum; Bacterial vaccine; Helicobacter pylori; Mucosal vaccine

Indexed keywords

ADJUVANT; ALUMINUM POTASSIUM SULFATE; CPG OLIGODEOXYNUCLEOTIDE; FREUND ADJUVANT; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN; RECOMBINANT UREASE B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL;

EID: 77953409961     PISSN: None     EISSN: 18750354     Source Type: Journal    
DOI: 10.2174/1875035400902010028     Document Type: Article

References (27)

1. Suerbaum, S.; Michetti, P. Helicobacter pylori infection. N. Engl. J. Med., 2002, 347 (15), 1175-1186.
2. Meyer, J.M.; Silliman, N.P.; Wang, W.; Siepman, N.Y.; Sugg, J.E.; Morris, D.; Zhang, J.; Bhattacharyya, H.; King, E.C.; Hopkins, R.J. Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. Ann. Intern. Med., 2002, 136 (1), 13-24.
3. Blanchard, T.G.; Czinn, S.J. Immunology of Helicobacter pylori and prospects for a vaccine. Gastroenterol. Clin. NA, 2000, 29 (3), 671-685. (Pubitemid 30757270)
4. Czinn, S.J.; Cai, A.; Nedrud, J.G. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine, 1993, 11 (6), 637-642.
5. Casswall, T.H.; Nilsson, H.O.; Björck, L.; Sjöstedt, S. Xu, L.; Nord, C.E.; Borén, T. Wadström, T. Bovine anti-Helicobacter pylori antibodies for oral immunotherapy Scand. J. Gastroenterol., 2002, 37 (12), 1380-1385. (Pubitemid 36051498)
6. Czinn, S.J.; Nedrud, J.G. Oral immunization against Helicobacter pylori. Infect. Immun., 1991, 59 (7), 2359-2363.
7. Futagami, S.; Takahashi, H.; Norose, Y.; Kobayashi, M. Systemic and local immune responses against Helicobacter pylori urease in patients with chronic gastritis: distinct IgA and IgG productive sites. Gut, 1998, 43 (2), 168-175.
8. Eaton, K.A.; Brooks, C.L.; Morgan, D.R.; Krakowka, S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun., 1991, 59 (7), 2470-2475.
9. Hirota, K.; Nagata, K.; Norose, Y.; Futagami, S.; Nakagawa, Y.; Senpuku, H.; Kobayashi, M.; Takahashi, H. Identification of an antigenic epitope in Helicobacter pylori urease that induces neutralizing antibody production. Infect. Immun., 2001, 69 (11), 6597-6603. (Pubitemid 32995413)
10. Ferrero, R.L.; Thiberge, J.M.; Huerre, M.; Labigne, A. Recombinant antigens prepared from urease subunits of Helicobacter spp: evidence of protection in a mouse model of gastric infection. Infect. Immun., 1994, 62 (11), 4981-4989. (Pubitemid 24332805)
11. Zavala-Spinetti, L.; Breslin, M.B.; Correa, H.; Bégué, R.E. Construction and evaluation of a Helicobacter pylori urease B DNA vaccine. Helicobacter, 2006, 11 (6), 517-522.
12. Bégué, R.E.; Cruz, A.R.; Ramgoolam, A.; Breslin, M.B. Immunogenicity of Helicobacter pylori urease B protein and DNA vaccines in a mouse model. J. Ped. Gastroenterol. Nutr., 2007, 45 (4), 493-496. (Pubitemid 350307175)
13. Kim, S.Y.; Doh, H.J.; Ahn, J.S.; Ha, Y.J.; Jang, M.H.; Chung, S.I.; Park, H.J. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly (D,L-lactide-co-glycolide) microparticles. Vaccine, 1999, 17 (6), 607-616.
14. Nakase, H.; Okazaki, K.; Tabata, Y.; Uchida, K.; Uose, S.; Ohana, M.; Nishi, T.; Watanabe, T.; Matsuura, M.; Hisatsune, H.; Matsumura, K.; Itoh, T.; Kawanami, C.; Chiba, T. Rectal immunization with antigen-containing microspheres induces stronger Th2 responses than oral immunization: a new method of vaccination. Vaccine, 2001, 20 (3-4), 377-384. (Pubitemid 32973779)
15. Shi, T.; Liu, W.-Z.; Gao, F.; Shi, G.-Y.; Xiao, S.-D. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper I type response and interferon-γ correlate with the protection. Helicobacter, 2005, 10 (1), 71-79.
16. McCluskie, M.J.; Davies, H.L. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine, 2000, 19 (4-5), 413-422.
17. Mantis, N.J.; McGuinnes, C.R. Protection of the intestinal epithelium from the direct effects of a shiga-like enterotoxin is conferred by anti-toxin serum IgG. FASEB J., 2008, 22 (4), 320.12.
18. Gottwein, J.M.; Blanchard, T.G.; Targoni, O.S.; Eisenberg, J.C.; Zagorski, B.M.; Redline, R.W.; Nedrud, J.G.; Tary-Lehmann, M.; Lehmann, P.V.; Czinn, S.J. Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization. J. Infect. Dis., 2001, 184 (3), 308-314.
19. Minoura, T.; Kato, S.; Otsu, S.; Fujioka, T.; Iinuma, K.; Nishizono, A. Childhood Helicobacter pylori infection in a murine model: maternal transmission and eradication by systemic immunization using bacterial antigen-aluminum hydroxide. Clin. Exp. Immunol., 2003, 134 (1), 32-37.
20. Nyström, J.; Raghavan, S.; Svennerholm, A.M. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes Infect., 2006, 8 (2), 442-449. (Pubitemid 43214607)
21. Maeda, K.; Yamashiro, T.; Minoura, T.; Fujioka, T.; Nasu, M.; Nishizono, A. Evaluation of therapeutic efficacy of adjuvant Helicobacter pylori whole cell sonicate in mice with chronic H. pylori infection. Microbiol Immunol., 2002, 46 (9), 613-620.
22. Lee, C.K.; Soike, K.; Giannasca, P.; Hill, J.; Weltzin, R.; Kleanthous, H.; Blanchard, J.; Monath, T.P. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine, 1999, 17 (23-24), 3072-3082.
23. Weltzin, R.; Guy, B.; Thomas, W.D, Jr.; Giannasca, P.J.; Monath, T.P. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection. Infect. Immun., 2000, 68 (5), 2775-2782.
24. Londoño-Arcila, P.; Freeman, D.; Kleanthous, H.; O'Dowd, A.M.; Lewis, S.; Turner, A.K.; Rees, E.M.; Tibbitts, T.J.; Greenwood, J.; Monath, T.P.; Darsley, M.J. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect. Immun., 2002, 70 (9), 5096-5106. (Pubitemid 34907323)
25. Moschos, S.A.; Bramwell, V.W.; Somavarapu, S.; Alpar, H.O. Modulating the adjuvanticity by co-administration of muramyl di-peptide (MDP) or Quil-A. Vaccine, 2006, 24 (8), 1081-1086.
26. Rossi, G.; Ruggiero, P.; Peppoloni, S.; Pancotto, L.; Fortuna, D.; Lauretti, L.; Volpini, G.; Mancianti, S.; Corazza, M.; Taccini, E.; Di Pisa, F.; Rappuoli, R.; Del Giudice, G. Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy. Infect. Immun., 2004, 72 (6), 3252-3259. (Pubitemid 38697746)
27. Malfertheiner, P.; Schultze, V.; Rosenkranz, B.; Kaufmann, S.H.E.; Ulrichs, T.; Novicki, D.; Norelli, F.; Contorni, M.; Peppoloni, S.; Berti, D.; Tornese, D.; Ganju, J.; Palla, E.; Rappuoli, R.; Scharschmidt, B.F.; Del Giudice, G. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers. A phase I study. Gastroenterology, 2008, 135 (3), 787-795.